- 首页
- ECHA 常见问答
- 详请
您是否总是建议对所评估的整组物质采取监管风险管理后续行动？
问题（中文）
您是否总是建议对所评估的整组物质采取监管风险管理后续行动？
Question (EN)
Do you always propose regulatory risk management follow up actions on the full group of substances assessed?
中文内容由 Google Cloud Translation 自动生成，仅供参考；请以英文原文为准。问答资料来自欧盟化学品管理局（ECHA）官方网站。
答案（中文）
ECHA 的初步分组为评估物质提供了一个有用的起点。然而，这并不一定意味着同一组内的所有物质都会被认定为相同的监管需求，也不一定意味着当局会针对整个组采取相同的监管行动。我们评估结果提出的行动可以针对整个组、子组或单个物质。例如，ECHA 可能会针对某一物质、组中的某个物质子集或整个组提出限制或 CLH 建议。
Answer (EN)
The initial grouping by ECHA provides a useful starting point for assessing substances. However, it does not necessarily mean that the same regulatory needs will be identified for all substances within a group or that the full group will be progressed towards the same regulatory action by authorities. Actions proposed as outcome of our assessments can be on the entire group, subgroup(s), or individual substance(s). For instance, ECHA may propose restriction or CLH for one substance, a sub-set of substances in the group or for the entire group.